CUTTING EDGE CONFIRMS DIRECT PRESENCE IN BELGIUM
Cutting Edge is delighted to annonce its direct commercial representation in Belgium and pursue its European geographical expansion strategy. Our ...
FIRST SYNTHESIS IMPLANTATION IN THE UNITED KINGDOM
Kestrel Ophthalmics (a Cutting Edge company) is delighted to announce its Synthesis preloaded system makes UK debut with consultant ophthalmologist ...
THE CORNERSTONE OF CATARACT SURGERY CAMPAIGN
Our UK subsidiary (Kestrel Ophthalmics Ltd – a Cutting Edge company) is launching its eye catching new campaign today ...
SYNTHESIS IOL LAUNCHES IN GERMANY
Cutting Edge is proud to present its Synthesis preloaded IOL system (our Concentrate of Innovations) at the 30th International Congress of German ...
UK NEW BRAND IDENTITY REVEALED AT THE RCO CONGRESS
Kestrel Ophthalmics (a Cutting Edge Company) announced today it launched its new brand identity at the Royal College of Ophthalmologists congress ...
CUTTING EDGE BEGINS COMMERCIAL OPERATIONS IN POLAND
Cutting Edge begins its commercial operations this month and attend the Polish Ophthalmic Conference today in Krakow. Discover the Inov8 ...
CUTTING EDGE SURGICAL ESPANA IS BORN!
Cutting Edge is proud to announce the opening of its Spanish offices, following successful registration of its newest IOLs, OVDs and retinal ...
SYNTHESIS PRELOADED IOLS NOW AVAILABLE IN ITALY
February 12, 2018, Montpellier, France. Cutting Edge SAS proudly announced today that our partner has successfully registered Synthesis Preloaded IOLs in the Italian Health’s ...
GENESIS – CE MARK APPROVAL
Genesis, the latest addition of the Cutting Edge IOL portfolio, received CE Mark approval. The lens is immediately available to ...
